News and Content
The Latest News from Agilex Biolabs
Author By Jeremy BurtPosted on
Unraveling the Untapped Potential of Immuno-Oncology Technology Both the pace and varied methods by which medical clinicians ut...
Author By Jeremy BurtPosted on
A Quick Look at Agilex Biolabs' Expertise and Capabilities In the intricate landscape of drug discovery and development, the as...
Author By Jeremy BurtPosted on
Agilex Biolabs has extensive knowledge on small molecule development and pharmacokinetic services. Today, pharmacokinetics (PK)...
Author By Jeremy BurtPosted on
Agilex Biolabs integrates critical reagents services into comprehensive lifecycle management. The relationship between producin...
Author By Jeremy BurtPosted on
Agilex is pleased to introduce Mallory Jolly as our new Senior Business Development Director to the East Coast of the United State...
Author By Jeremy BurtPosted on
Agilex Demystifies the Rapidly Evolving Landscape of Drug Development Post-Covid, the field of bioanalysis has undergone signif...
Author By Jeremy BurtPosted on
As Agilex Biolabs continues its global expansion and corporate evolution as part of the Healius network, Stephen McIntyre has been selected to take the position of Chief Executive Officer.
Author By Jeremy BurtPosted on
ddPCR technology provides an opportunity to streamline research and development processes, saving time and money. Digital dropl...
Author By Jeremy BurtPosted on
Small and large molecule drug development often necessitates distinct analytical methodologies. Agilex has extensive experience de...
Author By Jeremy BurtPosted on
Agilex has extensive experience developing and validating like-binding assays for specific immune-oncology therapeutics. From a...
Author By Jeremy BurtPosted on
Come to Our EBF Session in Barcelona to Hear how Agilex Can Make Your PK Data SPARCL SPARCL stands for Spatial Proximity Analyt...
Author By Jeremy BurtPosted on
How do Australia's streamlined regulatory process and global tax incentive apply to your toxicology studies? There are many ben...
Author By Jeremy BurtPosted on
As Agilex Biolabs continues its global expansion and corporate evolution as part of the Healius network, Stephen McIntyre has been selected to take the position of Chief Executive Officer.
Author By Jeremy BurtPosted on
by Holly Stefl, Chief Commercial Officer It is with much enthusiasm that Agilex Biolabs introduces its newest Senior Developmen...
Author By Jeremy BurtPosted on
by Kurt Sales In the realm of bioanalytical research, immunoassays stand as a cornerstone technology, enabling the precise dete...
Author By Jeremy BurtPosted on
by Holly Stefl, Chief Commercial Officer Agilex Biolabs is proud to introduce the West Coast of the United States to their new...
Author By Jeremy BurtPosted on
by Dr. Kurt Sales, Chief Scientific Officer Pharmacokinetics is a key component in a drug development program in enabling us to...
Author By Jeremy BurtPosted on
by Dr. Kurt Sales, Chief Scientific Officer In the ever-evolving landscape of pharmaceuticals, advancements in science have led...
Author By Jeremy BurtPosted on
Dr. Kurt Sales Presents Groundbreaking Findings at WRIB Conference Recently Dr. Kurt Sales, the Chief Scientific Officer of Agi...
Author By Jeremy BurtPosted on
by Kurt Sales The rise of Cell and Gene Therapy products is increasingly becoming more prevalent. At Agilex we are seeing more...
Author By Jeremy BurtPosted on
Agilex Biolabs, the leading bioanalytical laboratory supporting Australian clinical trials, has established its first satellite processing unit staffed with highly specialised technicians on the fifth floor of the CMAX Clinical Research facility in Adelaide, SA.
Author By Agilex BiolabsPosted on
Recent Report Shows Australia Rising to 3rd in Number of Industry-Initiated Phase I Clinical Trials in 2021 The Association of...
Author By Agilex BiolabsPosted on
As Agilex Biolabs continues its global expansion and corporate evolution as part of the Healius network, Stephen McIntyre has been selected to take the position of Chief Executive Officer.
Author By Agilex BiolabsPosted on
Rescue studies are a particular point of strength at Agilex Biolabs, where the bioanalytical experts are driven to solve challenges presented by what we call “the weird and wonderful”.